Telesis Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 27th of September, 2024.
40 hedge funds and large institutions have $139M invested in Telesis Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
22.38% more ownership
Funds ownership: 0% → 22.38% (+22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$14M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$12.7M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$11.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.8M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$10.1M |
Top Sellers
TBIO Hedge Fund Activity: Q2 2021 in Review
40 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Telesis Bio, Inc. Common Stock (TBIO) for Q2 2021, worth a combined $139M.
Buyers outnumbered sellers: 40 funds opened new TBIO positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $14M.
- 40 institutional investors held Telesis Bio, Inc. Common Stock (TBIO) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $139M of Telesis Bio, Inc. Common Stock stock for Q2 2021.
- 40 funds opened new Telesis Bio, Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +40 holders.
- The largest Telesis Bio, Inc. Common Stock buyer in Q2 2021 was Millennium Management, an estimated $14M added.
Based on aggregated 13F filings for Q2 2021.